Largest pharmaceutical companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 pharmaceutical companies ranked by total liabilities, at ZAR 2.37T, ahead of Pfizer (ZAR 2.1T) and Johnson & Johnson (ZAR 2.03T). Figures as of 18 Nov 2026, 18:07 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbVieZAR 2.37T
- Median
- ZAR 36B
- Combined market value
- ZAR 87.98T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | ZAR 2.37T | ZAR 8.8T | ZAR 4,976.12 | 1.54% down | 26% up | ||
| 2 | PfizerPFE · Health Care | ZAR 2.1T | ZAR 2.78T | ZAR 487.08 | 0.88% down | 14% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | ZAR 2.03T | ZAR 11.47T | ZAR 4,766.40 | 0.91% down | 38% up | ||
| 4 | Eli LillyLLY · Health Care | ZAR 1.48T | ZAR 21.46T | ZAR 24,091.61 | 1.40% down | 35% up | ||
| 5 | Merck & CoMRK · Health Care | ZAR 1.45T | ZAR 5.91T | ZAR 2,399.25 | 3.04% down | 51% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | ZAR 1.23T | ZAR 2.12T | ZAR 1,038.63 | 1.92% down | 34% up | ||
| 7 | AstraZenecaAZN · Health Care | ZAR 1.13T | ZAR 4.81T | ZAR 3,103.56 | 1.35% down | 2% up | ||
| 8 | NovartisNVS · Health Care | ZAR 1.11T | ZAR 5.09T | ZAR 2,695.35 | 1.87% down | 25% up | ||
| 9 | SanofiSNY · Health Care | ZAR 1.06T | ZAR 1.96T | ZAR 817.87 | 0.31% down | 4% down | ||
| 10 | GSKGSK · Health Care | ZAR 1.03T | ZAR 1.69T | ZAR 843.59 | 0.74% down | 6% up | ||
| 11 | Novo NordiskNVO · Health Care | ZAR 893.5B | ZAR 3.02T | ZAR 684.45 | 2.57% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | ZAR 873.5B | ZAR 1.18T | ZAR 369.63 | 1.04% down | 54% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | ZAR 585.8B | ZAR 3.13T | ZAR 1,808.35 | 0.06% up | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | ZAR 566.7B | ZAR 850.1B | ZAR 728.55 | 0.96% down | 74% up | ||
| 15 | ViatrisVTRS · Health Care | ZAR 388B | ZAR 409.1B | ZAR 356.85 | 1.10% up | 96% up | ||
| 16 | GrifolsGRFS · Health Care | ZAR 231.9B | ZAR 99.5B | ZAR 146.19 | 1.85% down | 1% up | ||
| 17 | ZoetisZTS · Health Care | ZAR 209.5B | ZAR 597.1B | ZAR 1,469.62 | 1.99% up | 29% down | ||
| 18 | Royalty PharmaRPRX · Health Care | ZAR 171B | ZAR 688B | ZAR 1,196.48 | 0.93% up | 78% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 160.6B | ZAR 1.69T | ZAR 16,370.09 | 0.97% down | 36% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | ZAR 126.7B | ZAR 272.8B | ZAR 4,250.32 | 2.30% up | 37% up | ||
| 21 | GenmabGMAB · Health Care | ZAR 121.3B | ZAR 548.1B | ZAR 888.91 | 0.88% down | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 120.4B | ZAR 2.35T | ZAR 9,285.64 | 0.71% up | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | ZAR 117.6B | ZAR 232.5B | ZAR 465.08 | 4.24% up | 20% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 72.1B | ZAR 349B | ZAR 2,605.77 | 3.53% down | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | ZAR 66.1B | ZAR 799.4B | ZAR 6,998.67 | 1.88% down | 17% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 63.4B | ZAR 132.5B | ZAR 380.41 | 4.36% up | 83% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | ZAR 53.6B | ZAR 87.1B | ZAR 1,042.00 | 0.02% up | 20% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | ZAR 52.4B | ZAR 79B | ZAR 474.31 | 1.93% up | 64% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | ZAR 52B | ZAR 262.7B | ZAR 1,348.45 | 1.73% up | 17% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 36.5B | ZAR 216.3B | ZAR 259.51 | 1.66% up | 5% up | ||
| 31 | CytokineticsCYTK · Health Care | ZAR 36B | ZAR 124.4B | ZAR 893.04 | 0.17% up | 20% down | ||
| 32 | Ascendis PharmaASND · Health Care | ZAR 28.1B | ZAR 307.9B | ZAR 4,694.26 | 0.29% up | 28% up | ||
| 33 | InsmedINSM · Health Care | ZAR 26.3B | ZAR 457.7B | ZAR 2,086.41 | 0.80% down | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 26B | ZAR 202.6B | ZAR 1,045.80 | 3.55% up | 11% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | ZAR 15.2B | ZAR 106.2B | ZAR 751.16 | 1.23% up | 10% up | ||
| 36 | United TherapeuticsUTHR · Health Care | ZAR 13.5B | ZAR 427.8B | ZAR 10,045.44 | 0.36% down | 23% up | ||
| 37 | Legend BiotechLEGN · Health Care | ZAR 12.6B | ZAR 54.4B | ZAR 280.31 | 0.81% up | 42% down | ||
| 38 | AlkermesALKS · Health Care | ZAR 11.5B | ZAR 135.9B | ZAR 808.81 | 3.10% up | 58% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 11.3B | ZAR 162.8B | ZAR 7,008.50 | 3.78% down | 24% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | ZAR 10.4B | ZAR 121.2B | ZAR 2,303.98 | 1.81% down | 7% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | ZAR 9.4B | ZAR 103.8B | ZAR 5,190.23 | 2.35% up | 43% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | ZAR 9.1B | ZAR 104.3B | ZAR 1,597.26 | 0.64% up | 31% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | ZAR 8.5B | ZAR 84.5B | ZAR 880.18 | 0.21% down | 44% up | ||
| 44 | Roivant SciencesROIV · Health Care | ZAR 7.2B | ZAR 482B | ZAR 665.21 | 0.44% down | 90% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | ZAR 7.2B | ZAR 171.9B | ZAR 1,137.45 | 5.09% up | 107% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | ZAR 5.2B | ZAR 84.3B | ZAR 484.67 | 0.83% up | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 3.6B | ZAR 142.2B | ZAR 2,051.29 | 1.92% up | 13% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | ZAR 3.4B | ZAR 128.9B | ZAR 1,639.93 | 0.10% down | 126% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | ZAR 3.3B | ZAR 128.9B | ZAR 1,177.84 | 2.61% down | 8% down | ||
| 50 | ABIVAXABVX · Health Care | ZAR 2.5B | ZAR 126.5B | ZAR 1,445.33 | 1.99% up | 27% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | ZAR 1.9B | ZAR 68.3B | ZAR 498.99 | 1.60% down | 169% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | ZAR 1.6B | ZAR 146.3B | ZAR 182.96 | 0.66% down | 36% down | ||
| 53 | ErascaERAS · Health Care | ZAR 1.2B | ZAR 80.2B | ZAR 228.53 | 4.68% down | 403% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | ZAR 1.1B | ZAR 158.3B | ZAR 1,666.47 | 2.92% up | 286% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | ZAR 1B | ZAR 148.1B | ZAR 5,298.88 | 0.64% up | 61% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | ZAR 923.1M | ZAR 141.3B | ZAR 2,164.77 | 0.60% up | 46% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | ZAR 647.6M | ZAR 84.6B | ZAR 1,501.81 | 0.03% up | 113% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | ZAR 523.8M | ZAR 79.1B | ZAR 722.60 | 0.42% down | 88% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | ZAR 288M | ZAR 113.4B | ZAR 1,671.31 | 0.53% up | 241% up | ||
| 60 | Belite BioBLTE · Health Care | ZAR 173.8M | ZAR 110.8B | ZAR 2,727.63 | 0.20% up | 31% up | ||
| 61 | VeradermicsMANE · Health Care | ZAR 158M | ZAR 90.3B | ZAR 2,139.06 | 1.36% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2602 ZAR).
Questions and answers
Which pharmaceutical companies rank first by total liabilities?
AbbVie (ZAR 2.37T), Pfizer (ZAR 2.1T) and Johnson & Johnson (ZAR 2.03T) are the top three of the 61 pharmaceutical companies ranked by total liabilities as of 18 Nov 2026, 18:07 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by total liabilities have a combined market value of ZAR 87.98T as of 18 Nov 2026, 18:07 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.